Literature DB >> 30938819

Chemokine Receptor 7 Is Essential for Coxiella burnetii Whole-Cell Vaccine-Induced Cellular Immunity but Dispensable for Vaccine-Mediated Protective Immunity.

Chen Chen1, Erin J van Schaik1, Anthony E Gregory1, Adam Vigil2, Phillip L Felgner2, Laura R Hendrix1, Robert Faris1, James E Samuel1.   

Abstract

BACKGROUND: Protective immunity against Coxiella burnetii infection is conferred by vaccination with virulent (PI-WCV), but not avirulent (PII-WCV) whole-cell inactivated bacterium. The only well-characterized antigenic difference between virulent and avirulent C. burnetii is they have smooth and rough lipopolysaccharide (LPS), respectively.
METHODS: Mice were vaccinated with PI-WCV and PII-WCV. Humoral and cellular responses were evaluated using protein chip microarrays and ELISpots, respectively. Dendritic cell (DC) maturation after stimulation with PI-WVC and PII-WVC was evaluated using flow cytometry. Vaccine-challenge studies were performed to validate the importance of the receptor CCR7.
RESULTS: Other than specific antibody response to PI-LPS, similar antibody profiles were observed but IgG titers were significantly higher after vaccination with PI-WCV. Furthermore, higher frequency of antigen-specific CD4+ T cells was detected in mice immunized with PI-WCV. PI-WCV-stimulated DCs displayed significantly higher levels of CCR7 and migratory ability to secondary lymphoid organs. Challenge-protection studies in wild-type and CCR7-deficient mice confirmed that CCR7 is critical for PI-WCV-induced cellular immunity.
CONCLUSIONS: PI-WVC stimulates protective immunity to C. burnetii in mice through stimulation of migratory behavior in DCs for protective cellular immunity. Additionally, the humoral immune response to LPS is an important component of protective immunity.
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  zzm321990 Coxiella burnetiizzm321990 ; IFN gamma; Nine Mile I; Nine Mile II; Q fever; cellular immune responses; humoral immune responses; protein array

Mesh:

Substances:

Year:  2019        PMID: 30938819      PMCID: PMC6639598          DOI: 10.1093/infdis/jiz146

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  37 in total

1.  Induction of rapid T cell activation, division, and recirculation by intratracheal injection of dendritic cells in a TCR transgenic model.

Authors:  B N Lambrecht; R A Pauwels; B Fazekas De St Groth
Journal:  J Immunol       Date:  2000-03-15       Impact factor: 5.422

2.  Analysis of the cells involved in the lymphoproliferative response to Coxiella burnetii antigens.

Authors:  A A Izzo; B P Marmion; T Hackstadt
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

3.  Mouse Naïve CD4+ T Cell Isolation and In vitro Differentiation into T Cell Subsets.

Authors:  Stephanie Flaherty; Joseph M Reynolds
Journal:  J Vis Exp       Date:  2015-04-16       Impact factor: 1.355

4.  Markers of cell-mediated immunity after vaccination with an inactivated, whole-cell Q fever vaccine.

Authors:  A A Izzo; B P Marmion; D A Worswick
Journal:  J Infect Dis       Date:  1988-04       Impact factor: 5.226

5.  Genome-wide profiling of humoral immune response to Coxiella burnetii infection by protein microarray.

Authors:  Adam Vigil; Rocio Ortega; Rie Nakajima-Sasaki; Jozelyn Pablo; Douglas M Molina; Chien-Chung Chao; Hua-Wei Chen; Wei-Mei Ching; Philip L Felgner
Journal:  Proteomics       Date:  2010-06       Impact factor: 3.984

6.  Role of antibody in Coxiella burnetii infection.

Authors:  R C Humphres; D J Hinrichs
Journal:  Infect Immun       Date:  1981-02       Impact factor: 3.441

Review 7.  Molecular pathogenesis of the obligate intracellular bacterium Coxiella burnetii.

Authors:  Erin J van Schaik; Chen Chen; Katja Mertens; Mary M Weber; James E Samuel
Journal:  Nat Rev Microbiol       Date:  2013-06-24       Impact factor: 60.633

8.  Immunogenicity and reactogenicity of a Q fever chemovaccine in persons professionally exposed to Q fever in Czechoslovakia.

Authors:  J Kazár; R Brezina; A Palanová; B Tvrdá; S Schramek
Journal:  Bull World Health Organ       Date:  1982       Impact factor: 9.408

9.  Lipopolysaccharide variation in Coxiella burnetti: intrastrain heterogeneity in structure and antigenicity.

Authors:  T Hackstadt; M G Peacock; P J Hitchcock; R L Cole
Journal:  Infect Immun       Date:  1985-05       Impact factor: 3.441

10.  Immunoreactive Coxiella burnetii Nine Mile proteins separated by 2D electrophoresis and identified by tandem mass spectrometry.

Authors:  James R Deringer; Chen Chen; James E Samuel; Wendy C Brown
Journal:  Microbiology (Reading)       Date:  2010-10-28       Impact factor: 2.777

View more
  3 in total

Review 1.  Immunogenicity and Reactogenicity in Q Fever Vaccine Development.

Authors:  Alycia P Fratzke; Erin J van Schaik; James E Samuel
Journal:  Front Immunol       Date:  2022-05-26       Impact factor: 8.786

2.  A Novel Marmoset (Callithrix jacchus) Model of Human Inhalational Q Fever.

Authors:  Michelle Nelson; Francisco J Salguero; Laura Hunter; Timothy P Atkins
Journal:  Front Cell Infect Microbiol       Date:  2021-01-28       Impact factor: 5.293

3.  Soluble antigens derived from Coxiella burnetii elicit protective immunity in three animal models without inducing hypersensitivity.

Authors:  Anthony E Gregory; Erin J van Schaik; Alycia P Fratzke; Kasi E Russell-Lodrigue; Christina M Farris; James E Samuel
Journal:  Cell Rep Med       Date:  2021-12-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.